QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 william-blair-reiterates-outperform-on-simulations-plus

William Blair analyst Max Smock reiterates Simulations Plus (NASDAQ:SLP) with a Outperform.

 keybanc-initiates-coverage-on-simulations-plus-with-overweight-rating-announces-price-target-of-47

Keybanc analyst Scott Schoenhaus initiates coverage on Simulations Plus (NASDAQ:SLP) with a Overweight rating and announces ...

 jmp-securities-initiates-coverage-on-simulations-plus-with-market-perform-rating

JMP Securities analyst Constantine Davides initiates coverage on Simulations Plus (NASDAQ:SLP) with a Market Perform rating.

 simulations-plus-announces-new-research-project-with-the-international-collaboration-on-cosmetics-safety-to-evaluate-the-use-of-physiologically-based-kinetic-modeling-approaches-to-advance-animal-free-science-for-cosmetics-and-other-non-pharmaceutical-ingredients

Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new...

 craig-hallum-reiterates-buy-on-simulations-plus-maintains-56-price-target

Craig-Hallum analyst Matt Hewitt reiterates Simulations Plus (NASDAQ:SLP) with a Buy and maintains $56 price target.

 simulations-plus-has-determined-to-discontinue-its-quarterly-cash-dividend-and-reallocate-these-funds-to-its-capital-allocation-strategy-for-investing-in-growth-initiatives

Quarterly DividendThe Simulations Plus Board of Directors has determined to discontinue the Company's quarterly cash divide...

 simulations-plus-sees-fy24-eps-046-048-vs-055-est-revenue-69m-72m-vs-7088m-est

Fiscal 2024 Guidance  Fiscal 2024GuidanceRevenue $69M - $72MRevenue growth 15 - 20%Software mix 55 - 60%Services mix 40 - 45%Di...

 simulations-plus-q3-adj-015-inline-sales-1854m-beat-1796m-estimate

Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is ...

 nasdaq-closes-at-record-high-led-by-microsoft-and-apple-fear--greed-index-in-neutral-zone

Market sentiment improved as Nasdaq gains record level. S&P 500 and Dow Jones also rose, while some sectors closed negative...

 william-blair-initiates-coverage-on-simulations-plus-with-outperform-rating

William Blair analyst Max Smock initiates coverage on Simulations Plus (NASDAQ:SLP) with a Outperform rating.

 craig-hallum-maintains-buy-on-simulations-plus-raises-price-target-to-56

Craig-Hallum analyst Matt Hewitt maintains Simulations Plus (NASDAQ:SLP) with a Buy and raises the price target from $51 to ...

 oppenheimer-maintains-outperform-on-simulations-plus-raises-price-target-to-65

Oppenheimer analyst Francois Brisebois maintains Simulations Plus (NASDAQ:SLP) with a Outperform and raises the price target...

 qhp-capital-lp-announced-its-sale-of-pro-ficiency-llc-to-simulations-plus-no-financial-terms-disclosed

QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors...

 simulations-plus-acquires-pro-ficiency-for-100m-expanding-reach-across-drug-development-spectrum

The transaction expands Simulations Plus' presence across the drug development continuum from establishing pre-clinical pro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION